the core of our corporate values
Since the launch of its products, Zhuhai TonBridge Medical Technology Co., Ltd. has seen rapid growth in sales revenue. In November 2020, it has successfully upgrade of small and micro industrial ente...
In October 2020, TonBridge Medical held a launch meeting for the Clot Retriever Device and the Intracranial Support Catheters at the OCIN2020 Innovation Forum. At the meeting, Liu Jianmin and many oth...
In September 2020, the Clot Retriever Device independently developed by Zhuhai TonBridge Medical Technology Co., Ltd. obtained the medical device registration certificate approved by NMPA.The Clot Ret...
In September 2020, the Intracranial Support Catheter independently developed by Zhuhai TonBridge Medical Technology Co., Ltd. obtained the medical device registration certificate approved by NMPA.The ...
In January 2020, ThromBite™ Clot Retriever Device, independently developed by Zhuhai TonBridge Medical Tech. Co., Ltd, gained CE certificate.ThromBite™ Clot Retriever Device is designed for the trea...
Recently, the Billboard of the "Top 50 Most Valuable Investment Companies in China" in 2019 have been unveiled. As the first domestic company with an investment dimension, Venture50 has acco...